Viewing nowCombinationEmpagliflozin/Metformin Tablets 5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.

MFDS item code 202201399 · Approved 2022.04.04 · Insurance code 646005530
Improvement of glycemic control in adults with type 2 diabetes
This medication is primarily used to improve blood sugar control in adults with type 2 diabetes. It is administered as an adjunct to diet and exercise therapy using a combination of empagliflozin and metformin. It is particularly effective in patients whose blood sugar is not well controlled. Caution is also required when administering this medication to type 2 diabetic patients with cardiovascular disease. This medication helps improve blood sugar control and aids in overall diabetes management.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication contains two components that help control blood sugar and is used for diabetes treatment. However, caution is needed as rare side effects such as severe lactic acidosis may occur. Lactic acidosis can lead to a dangerous condition caused by the excessive accumulation of lactic acid in the body and can sometimes be life-threatening. Additionally, caution is necessary since hypoglycemia, or very low blood sugar, may occur when used with other diabetes medications. This medication should not be administered to patients with moderate to severe renal impairment, acute renal problems, severe infections, heart failure, or acute myocardial infarction. Moreover, the use of this medication should be temporarily halted before and after undergoing examinations that utilize iodinated contrast agents, and it should be resumed only after renal function is confirmed to be normal. It is advisable that women who are pregnant or may become pregnant, and those who are nursing, avoid taking this medication. Regular kidney function tests should be performed while on this medication, especially in situations where there is a risk of reduced fluid volume due to dehydration, severe vomiting or diarrhea. This medication can increase the risk of urinary and genital infections, so immediate consultation with a doctor is necessary if any symptoms of infection appear. Also, this medication may lower vitamin B12 levels, so it is advisable to monitor for vitamin B12 levels during long-term use. Alcohol intake can increase the risk of lactic acidosis, so excessive drinking should be avoided while on this medication. In elderly patients, the dosage should be adjusted and condition monitored regularly considering the risks of decreased kidney function and loss of fluid volume. Hypoglycemia may occur, so careful monitoring of blood sugar changes is particularly important when taken together with insulin or other blood sugar-lowering agents. In case of suspected drug overdose, immediate medical attention should be sought for appropriate treatment, especially if lactic acidosis is suspected. While taking this medication, it is important to undergo regular tests as directed by a doctor and consult immediately if any unusual symptoms arise.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Moreover, it is best to avoid extremely hot or cold places and store it at room temperature between 1 to 30 degrees Celsius.
Yellow film-coated tablets that are convex on both sides with a brownish tint.
10 tablets/box[(10 tablets/PTP x 1)], 60 tablets/box[(10 tablets/PTP x 6)], 60 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.